Bioconjugate Chemistry · 2011 · 70 citations · 17 references
EngineeringBiomolecular EngineeringMolecular BiologyMolecular VirologyProtein EngineeringStructural BiologyProtein DesignProtein StructureTherapeutic Protein EngineeringCleavageHydrazone FormationHydrazone LigationPegylationProtein PegylationRecombinant Fusion ProteinsTherapeutic Proteins
Here, we describe a novel method for the site-specific C-terminal PEGylation of recombinant proteins. This general approach exploits chemical cleavage of precursor intein-fusion proteins with hydrazine to directly produce recombinant protein hydrazides. This unique functionality within the protein sequence then facilitates site-specific C-terminal modification by hydrazone-forming ligation reactions. This approach was used to generate folded, site-specifically C-terminal PEGylated IFNalpha2b and IFNbeta1b, which retained excellent antiviral activity, demonstrating the utility of this technology in the PEGylation of therapeutic proteins. As this methodology is straightforward to perform, is compatible with disulfide bonds, and is exclusively selective for the protein C-terminus, it shows great potential as general technology for the site-specific engineering and labeling of recombinant proteins.
17
Synthesis of Proteins by Native Chemical Ligation
Philip E. Dawson, Tom W. Muir, Ian Clark‐Lewis et al. · Science · 1994 · 4.1K citations
Amartya Basu, Karen Yang, Maoliang Wang et al. · Bioconjugate Chemistry · 2006 · 214 citations
GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli
Shawn DeFrees, Zhiguang Wang, Ruye Xing et al. · Glycobiology · 2006 · 171 citations · Full text
Neutralizing antibodies reduce the efficacy of βIFN during treatment of multiple sclerosis
Simona Malucchi, Arianna Sala, Francesca Gilli et al. · Neurology · 2004 · 152 citations